Company / CapEx per Share
Altimmune, Inc. CapEx per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.30
FY2021-FY2025
Trend
-77.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has declined for 3 consecutive years, from $0.30 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of +13.7%.
Declined from $0.00 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -92.0%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Altimmune, Inc.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 77.1% year-over-year.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -77.1% |
| FY2024 | $0.00 | -74.0% |
| FY2023 | $0.00 | -99.1% |
| FY2022 | $0.30 | +5282.9% |
| FY2021 | $0.01 | +6752.6% |
| FY2020 | $0.00 | -99.9% |
| FY2019 | $0.11 | -41.9% |
| FY2018 | $0.18 | +922.9% |
| FY2017 | $0.02 | +123.0% |
| FY2011 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026